⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1650712 | 1.00 | — | — | |
| SCHEMBL1651824 | 1.00 | — | — | |
| SCHEMBL27129580 | 0.97 | MEN1 (0.56) | — | |
| SCHEMBL58260 | 0.86 | — | — | |
| Hydrochloric Acid SCHEMBL1133986 | 0.83 | MEN1 (0.62) | — | |
| SCHEMBL1923397 | 0.83 | — | — | |
| Acetic Acid SCHEMBL103302 | 0.81 | MEN1 (0.60) | — | |
| SCHEMBL77047 | 0.80 | ARG2 (0.52) | — | |
| SCHEMBL8240842 | 0.80 | MEN1 (0.65) | — | |
| SCHEMBL3100239 | 0.80 | ARG2 (0.52) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230158179-A1 | RADIOPHARMACEUTICAL CONJUGATE COMPOSITIONS AND USES THEREOF | RAYZEBIO, INC. | 2023-05-25 | — | — | US | disclosed |
| US-20230158179-A1 | RADIOPHARMACEUTICAL CONJUGATE COMPOSITIONS AND USES THEREOF | RAYZEBIO, INC. | 2023-05-25 | — | — | US | disclosed |
| CN-114761420-A | Optimized GIP peptide analogs | 安泰博医药 | 2022-07-15 | — | — | CN | disclosed |
| EP-2239335-B1 | PROCESS FOR PRODUCTION OF SERINE DERIVATIVE, AND PROTEIN FOR USE IN THE PROCESS | AJINOMOTO KK (JP) | 2013-02-27 | — | — | EP | disclosed |
| US-8372607-B2 | Method for producing serine derivative and protein used for the same | AJINOMOTO CO., INC. (JP) | 2013-02-12 | — | — | US | disclosed |
| EP-1882737-B1 | PROCESS FOR PRODUCTION OF L-SERINE DERIVATIVE AND ENZYME USED IN THE PROCESS | AJINOMOTO KK (JP) | 2011-09-14 | — | — | EP | disclosed |
| US-20100317068-A1 | METHOD FOR PRODUCING SERINE DERIVATIVE AND PROTEIN USED FOR THE SAME | AJINOMOTO CO., INC. (JP) | 2010-12-16 | — | — | US | disclosed |
| US-7851187-B2 | Method of producing L-serine derivative and enzyme used therefore | AJINOMOTO CO., INC. (JP) | 2010-12-14 | — | — | US | disclosed |
| EP-2239335-A1 | PROCESS FOR PRODUCTION OF SERINE DERIVATIVE, AND PROTEIN FOR USE IN THE PROCESS | Ajinomoto Co., Inc. (JP) | 2010-10-13 | — | — | EP | disclosed |
| US-20090170171-A1 | Method of Producing L-Serine Derivative and Enzyme Used Therefore | AJINOMOTO CO., INC. (JP) | 2009-07-02 | — | — | US | disclosed |
| EP-1882737-A1 | PROCESS FOR PRODUCTION OF L-SERINE DERIVATIVE AND ENZYME USED IN THE PROCESS | Ajinomoto Co., Inc. (JP) | 2008-01-30 | — | — | EP | disclosed |
| US-7256021-B2 | Enterobacteriaceae strains with an attenuated aspA gene for the fermentative production of amino acids | DEGUSSA AG (DE) | 2007-08-14 | — | — | US | disclosed |
| US-20040115780-A1 | Process for the preparation of l-amino acids using strains of the enterobacteriaceae family which contain an atteuated aspa gene | EVONIK DEGUSSA GMBH (DE) | 2004-06-17 | — | — | US | disclosed |